Department of Hepatobiliary Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Front Med. 2012 Sep;6(3):317-21. doi: 10.1007/s11684-012-0203-9. Epub 2012 Jul 14.
In order to find out the potential indicators predicting prognosis of malignant gastrointestinal stromal tumors (GISTs) after surgical resection, we collected clinical records of 80 patients with malignant GISTs. Tumor location, size, mitotic index, necrosis were compared with the prognosis of malignant GISTs by Kaplan-Meier method and log-rank test. After a median follow-up of 844 days (52-2 145), we found that as National Institutes of Health suggested, tumors with intermediate risk had more favorable prognosis than that with high risk. Their 3-year survival rate were 65.3% and 41.3%, respectively (P < 0.001). Moreover, tumor size and mitotic index were associated with free survival. The 3-year survival rate for patients with tumor size ≤ 10 cm and > 10 cm were 62.3% and 41.8%, respectively (P = 0.002), Tumors with mitotic index ≤ 5/50 HPF had a higher 3-year survival rate than tumors with mitotic index > 5/50 HPF (67.1% versus 40.7%, P = 0.005). The presence of necrosis was directly related to the malignant behavior. The 3-year survival rate for presence and absence necrosis were 50.8% and 64.8% (P = 0.008). From the present study, we can conclude that besides tumors size and mitotic index, tumor location and necrosis also influence on the long-term survival of patient with malignant GISTs after surgical resection.
为了寻找预测恶性胃肠道间质瘤(GIST)术后预后的潜在指标,我们收集了 80 例恶性 GIST 患者的临床资料。采用 Kaplan-Meier 法和对数秩检验比较肿瘤位置、大小、有丝分裂指数、坏死与恶性 GIST 预后的关系。中位随访 844 天(52-2145 天)后,我们发现按照美国国立卫生研究院(NIH)的建议,中危肿瘤的预后优于高危肿瘤。其 3 年生存率分别为 65.3%和 41.3%(P<0.001)。此外,肿瘤大小和有丝分裂指数与无复发生存有关。肿瘤直径≤10cm 和>10cm 的患者 3 年生存率分别为 62.3%和 41.8%(P=0.002),有丝分裂指数≤5/50HPF 的患者 3 年生存率高于有丝分裂指数>5/50HPF 的患者(67.1%比 40.7%,P=0.005)。肿瘤坏死的存在与恶性行为直接相关。存在和不存在肿瘤坏死的患者 3 年生存率分别为 50.8%和 64.8%(P=0.008)。本研究表明,除了肿瘤大小和有丝分裂指数外,肿瘤位置和坏死也影响恶性 GIST 患者术后的长期生存。